Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983772 · ClinicalTrials.gov registry record · NA
Resistant Starch Blend Gastrointestinal Impact
A NA study, sponsored by Metagenics.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT03983772 is a NA study that has completed, run by Metagenics. The registered enrollment target is 43 participants.
The verdict
NCT03983772, a NA study, has completed, sponsored by Metagenics.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study aims to test the hypothesis that a unique blend of resistant starches and fiber will promote gastrointestinal health, as measured by an increase in short-chain fatty acids and improvement in quality of life measures in conjunction with microbial community changes. This study specifically evaluates the impact on short-chain fatty acids and gut microbiota and the impact on quality of life from a resistant starch blend in healthy adult humans with occasional gastrointestinal distress.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT RS blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-06-14 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03983772
The ClinicalTrials.gov registry entry for NCT03983772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metagenics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03983772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03983772 about?
NCT03983772 is a clinical study titled "Resistant Starch Blend Gastrointestinal Impact". This study aims to test the hypothesis that a unique blend of resistant starches and fiber will promote gastrointestinal health, as measured by an increase in short-chain fatty acids and improvement in quality of life measures in conjunction with microbial community changes. This study specifically ...
What is the current status of trial NCT03983772?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2019-06-14. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03983772?
The interventions under investigation include: Placebo (OTHER), RS blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03983772?
This trial is sponsored by Metagenics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.